Core Points - Medtronic plc's board of directors approved a cash dividend of $0.70 per ordinary share for the fourth quarter of fiscal year 2025, consistent with a previous dividend increase announced in May 2024 [1] - Medtronic has a strong history of dividend payments, having increased its annual dividend for 47 consecutive years, and is part of the S&P 500 Dividend Aristocrats index [1] - The dividend will be payable on April 11, 2025, to shareholders of record as of March 28, 2025 [1] Company Overview - Medtronic, headquartered in Galway, Ireland, is a leading global healthcare technology company focused on addressing significant health challenges through innovative solutions [2] - The company's mission is to alleviate pain, restore health, and extend life, supported by a global workforce of over 95,000 employees across more than 150 countries [2] - Medtronic's technologies and therapies address 70 health conditions, including cardiac devices, surgical robotics, insulin pumps, and patient monitoring systems [2]

Group 1 - Advanced Micro Devices (AMD) experienced a significant price fluctuation, peaking at approximately $211 in March 2024 before declining to around $99 [1] - The company's stock performance was previously driven by enthusiasm surrounding AI infrastructure [1] - The investment strategy discussed combines fundamental analysis with options trading, focusing on various strategies including income-oriented investments, growth at a reasonable price, deep value, and dividend aristocrats [1] Group 2 - The analyst has a beneficial long position in AMD shares through stock ownership, options, or other derivatives [2] - The article reflects the author's personal opinions and is not influenced by compensation from any company mentioned [2]